SEC Form D private-offering filing

RenovoRx, Inc.

Name: RenovoRx, Inc. - new SEC Form D private-offering filing, Mountain View, CA
Published: 2026-04-09

A new SEC Form D private-offering notice from Mountain View, CA, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.

RenovoRx, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing intra arterial cancer therapies and the FDA cleared RenovoCath drug delivery device

Filed 2026-04-09Filed to raise $10,000,000First money in 2026-03-20Raised so far $9,999,929HQ (as filed) Mountain View, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified renovorx.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.